Urine neutrophil gelatinase-associated lipocalin (uNGAL) and netrin-1: Are they effectively improving the clinical management of sepsis-induced acute kidney injury (AKI)?

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue SUPPL. 2, 2011, Pages 16-18

  Mussap, Michele ^a   Noto, Antonio ^b   Fravega, Marco ^a   Fanos, Vassilios ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Netrin 1; Sepsis induced acute kidney injury; Urine neutrophil gelatinase associated lipocalin

Indexed keywords

CREATININE; NETRIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN; LIPOCALIN; NERVE GROWTH FACTOR; NETRIN-1; ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN;

ACUTE KIDNEY FAILURE; APOPTOSIS; BLEEDING; CRITICALLY ILL PATIENT; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; HEART FAILURE; HENLE LOOP; HUMAN; KIDNEY BLOOD FLOW; KIDNEY COLLECTING TUBULE; KIDNEY DYSFUNCTION; KIDNEY PERFUSION; LENGTH OF STAY; MORTALITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN DEATH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SEPSIS; SEPTIC SHOCK; UPREGULATION; URINARY EXCRETION; VASODILATATION; EVALUATION; NEWBORN; NEWBORN DISEASE; PREDICTIVE VALUE; TREATMENT OUTCOME; URINALYSIS; URINE;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LIPOCALINS; NERVE GROWTH FACTORS; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS; SEPSIS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEINS; URINALYSIS;

EID: 80053549893     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.603913     Document Type: Review

References (17)

1. Bagshaw SM, Lapinsky S, Dial S, Arabi Y, Dodek P, Wood G, Ellis P, et al.; Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group. Acute kidney injury in septic shock: Clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 2009;35:871-881.
2. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, et al. Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007;2:431-439.
3. Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, Bellomo R. Pathophysiology of septic acute kidney injury: What do we really know? Crit Care Med 2008;36:S198-S203. (Pubitemid 351483052)
4. Lerolle N, Nochy D, Guérot E, Bruneval P, Fagon JY, Diehl JL, Hill G. Histopathology of septic shock induced acute kidney injury: Apoptosis and leukocytic infiltration. Intensive Care Med 2010; 36:471-478.
5. Joannes-Boyau O, Honoré PM, Boer W, Rose T. Septic acute kidney injury and tubular apoptosis: Never a Lone Ranger. Intensive Care Med 2010;36:385-388.
6. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001;345:588-595.
7. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004;351:159-169.
8. Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, Himmelfarb J. Program to Improve Care in Acute Renal Disease (PICARD) Study Group. Sepsis as a cause and consequence of acute kidney injury: Program to improve care in acute renal disease. Intensive Care Med 2011;37:241-248.
9. Honoré PM, Jacobs R, Boer W, Joannes-Boyau O. Sepsis and AKI: More complex than just a simple question of chicken and egg. Intensive Care Med 2011;37:186-189.
10. Kjeldsen L, Bainton DF, Sengeløv H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 1994;83: 799-807. (Pubitemid 24043742)
11. Schmidt-Ott KM, Mori K, Kalandadze A, Li JY, Paragas N, Nicholas T, Devarajan P, Barasch J. Neutrophil gelatinase-associated lipocalinmediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens 2006;15:442-449. (Pubitemid 44297988)
12. Schmidt-Ott KM, Mori K, Li JY, Kalandadze A, Cohen DJ, Devarajan P, Barasch J. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2007;18:407-413. (Pubitemid 46193306)
13. Grenier FC, Ali S, Syed H, Workman R, Martens F, Liao M, Wang Y, Wong PY. Evaluation of the ARCHITECT urine NGAL assay: Assay performance, specimen handling requirements and biological variability. Clin Biochem 2010;43:615-620.
14. Cai L, Rubin J, Han W, Venge P, Xu S. The origin of multiple molecular forms in urine of HNL/NGAL. Clin J Am Soc Nephrol 2010;5:2229-2235.
15. Serafini T, Kennedy TE, Galko MJ, Mirzayan C, Jessell TM, Tessier-Lavigne M. The netrins define a family of axon out growth promoting proteins homologous to C. elegans UNC-6. Cell 1994;78: 409-424. (Pubitemid 24250806)
16. Mehlen P, Furne C. Netrin-1: When a neuronal guidance cue turns out to be a regulator of tumorigenesis. Cell Mol Life Sci 2005;62: 2599-2616. (Pubitemid 41721233)
17. Mussap M, Degrandi R, Fravega M, Fanos V. Acute kidney injury in critically ill infants: the role of urine Neutrophil Gelatinase-Associated Lipocalin (NGAL). J Matern Fetal Neonatal Med. 2010 Oct;23 Suppl 3:70-2.